{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:55:35Z","timestamp":1781812535916,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Interv and Ther"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12928-026-01248-4","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:21:23Z","timestamp":1772551283000},"page":"491-509","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Drug-coated balloons in coronary in-stent restenosis: a systematic review and meta-analysis comparing sirolimus and biolimus with paclitaxel platforms"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-3580-0783","authenticated-orcid":false,"given":"Mrunalini","family":"Dandamudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Aqib","family":"Faizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Rehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Lecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyothik Varun","family":"Inampudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Cedric","family":"Mojica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salomon","family":"Chamay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana","family":"Giorgi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"1248_CR1","doi-asserted-by":"publisher","unstructured":"Mangner N, Farah A, Ohlow MA, M\u00f6bius-Winkler S, Weilenmann D, W\u00f6hrle J, et al. Safety and Efficacy of Drug-Coated Balloons Versus Drug-Eluting Stents in Acute Coronary Syndromes: A Prespecified Analysis of BASKET-SMALL 2. Circulation: Cardiovas Inter. 2022 Feb [cited 2025 Sept 1];15(2):[e011325 p.]. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.121.011325","DOI":"10.1161\/CIRCINTERVENTIONS.121.011325"},{"key":"1248_CR2","doi-asserted-by":"publisher","unstructured":"Liu H, Li Y, Fu G, An J, Chen S, Zhong Z, et al. Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis. JACC: CardiovasInterv. 2025 Apr 28 [cited 2025 Sept 1];18(8):[963\u201371 p.]. Available from: https:\/\/www.jacc.org\/doi\/https:\/\/doi.org\/10.1016\/j.jcin.2024.12.024","DOI":"10.1016\/j.jcin.2024.12.024"},{"key":"1248_CR3","doi-asserted-by":"crossref","unstructured":"Ninomiya K, Serruys PW, Colombo A, Reimers B, Basavarajaiah S, Sharif F, et al. A Prospective Randomized Trial Comparing Sirolimus-Coated Balloon With Paclitaxel-Coated Balloon in De Novo Small Vessels. JACC: CardiovasInterv. 2023 Dec [cited 2025 Sept 1];16(23):[2884\u201396 p.]. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879823013213","DOI":"10.1016\/j.jcin.2023.09.026"},{"key":"1248_CR4","doi-asserted-by":"crossref","unstructured":"Authors\/Task Force members, Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, et al. ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J. 2014 Oct 1;35(37):2541\u2013619.","DOI":"10.1093\/eurheartj\/ehu278"},{"key":"1248_CR5","unstructured":"Department of Cardiology, University Hospital Merkur, Zagreb, Croatia, Radoni\u0107 V. Evidence on Treating Coronary Artery Disease with Drug-Coated Balloons. PJC. 2025 [cited 2025 Sept 1]; Available from: https:\/\/premierscience.com\/pjc-25-818\/"},{"key":"1248_CR6","doi-asserted-by":"crossref","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021 Mar 29 [cited 2025 Sept 1];372:[n71 p.]. Available from: https:\/\/www.bmj.com\/content\/372\/bmj.n71","DOI":"10.1136\/bmj.n71"},{"key":"1248_CR7","unstructured":"Cochrane Handbook for Systematic Reviews of Interventions | Cochrane. [cited 2025 Sept 1]. Available from: https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook"},{"issue":"366","key":"1248_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l4898","volume":"28","author":"JAC Sterne","year":"2019","unstructured":"Sterne JAC, Savovi\u0107 J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;28(366):l4898.","journal-title":"BMJ"},{"issue":"5","key":"1248_CR9","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCINTERVENTIONS.124.014677","volume":"18","author":"L Pleva","year":"2025","unstructured":"Pleva L, Kukla P, Kovarnik T, Zapletalova J. Comparing the efficacy of sirolimus and paclitaxel-eluting balloon catheters in the treatment of coronary in-stent restenosis: a prospective randomized study (TIS 2 Study). Circ Cardiovasc Interv. 2025;18(5):e014677.","journal-title":"Circ Cardiovasc Interv"},{"key":"1248_CR10","doi-asserted-by":"publisher","unstructured":"Liu H, Li Y, Fu G, An J, Chen S, Zhong Z, et al. Sirolimus- vs Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis. JACC: CardiovasInterv. 2025 Apr 28 [cited 2025 Sept 1];18(8):[963\u201371 p.]. Available from: https:\/\/www.jacc.org\/doi\/abs\/https:\/\/doi.org\/10.1016\/j.jcin.2024.12.024","DOI":"10.1016\/j.jcin.2024.12.024"},{"issue":"6","key":"1248_CR11","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.jcin.2018.11.040","volume":"12","author":"RM Ali","year":"2019","unstructured":"Ali RM, Abdul Kader MASK, Wan Ahmad WA, Ong TK, Liew HB, Omar AF, et al. Treatment of Coronary Drug-Eluting Stent Restenosis by a Sirolimus- or Paclitaxel-Coated Balloon. JACC Cardiovasc Interv. 2019;12(6):558\u201366.","journal-title":"JACC Cardiovasc Interv"},{"key":"1248_CR12","doi-asserted-by":"publisher","unstructured":"Scheller B, Mangner N, Abdul Kader MASK, Wan Ahmad WA, Jeger R, W\u00f6hrle J, et al. Combined Analysis of Two Parallel Randomized Trials of Sirolimus-Coated and Paclitaxel-Coated Balloons in Coronary In-Stent Restenosis Lesions. Circulation: Cardiovas Interv. 2022 Sept [cited 2025 Sept 1];15(9):[e012305 p.]. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.122.012305","DOI":"10.1161\/CIRCINTERVENTIONS.122.012305"},{"key":"1248_CR13","doi-asserted-by":"crossref","unstructured":"Byrne RA, Hahn JY, O\u2019Kane P, Sabat\u00e9 M, Toelg R, Copt S, et al. Randomized Trial of Biolimus DCB for In-Stent Restenosis. JACC: CardiovasInterv. 2025 Mar [cited 2025 Sept 1];18(5):[654\u201362 p.]. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879824017370","DOI":"10.1016\/j.jcin.2024.11.026"},{"issue":"13","key":"1248_CR14","doi-asserted-by":"publisher","first-page":"e806","DOI":"10.4244\/EIJ-D-24-00295","volume":"20","author":"Y Chen","year":"2024","unstructured":"Chen Y, Gao L, Qin Q, Zhang J, Jia S, Wu M, et al. Biolimus-coated versus paclitaxel-coated balloons for coronary in-stent restenosis (BIO ASCEND ISR): a randomised, non-inferiority trial. EuroIntervention. 2024;20(13):e806\u201317.","journal-title":"EuroIntervention"},{"key":"1248_CR15","doi-asserted-by":"publisher","unstructured":"Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, Van Es GA, et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions. Circulation. 2007 May [cited 2025 Sept 1];115(17):[2344\u201351 p.]. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.685313","DOI":"10.1161\/CIRCULATIONAHA.106.685313"},{"key":"1248_CR16","doi-asserted-by":"crossref","unstructured":"Alfonso F, Byrne RA, Rivero F, Kastrati A. Current Treatment of In-Stent Restenosis. J Am Coll Cardiol. 2014 June [cited 2025 Sept 1];63(24):[2659\u201373 p.]. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109714013540","DOI":"10.1016\/j.jacc.2014.02.545"},{"key":"1248_CR17","doi-asserted-by":"publisher","unstructured":"Shlofmitz E, Iantorno M, Waksman R. Restenosis of Drug-Eluting Stents: A New Classification System Based on Disease Mechanism to Guide Treatment and State-of-the-Art Review. Circ: Cardiovas Interv. 2019 Aug [cited 2025 Sept 1];12(8):[e007023 p.]. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.007023","DOI":"10.1161\/CIRCINTERVENTIONS.118.007023"},{"key":"1248_CR18","doi-asserted-by":"publisher","unstructured":"Stone GW, Ellis SG, Cannon L, Mann JT, Greenberg JD, Spriggs D, et al. Comparison of a Polymer-Based Paclitaxel-Eluting Stent With a Bare Metal Stent in Patients With Complex Coronary Artery Disease: A Randomized Controlled Trial. JAMA. 2005 Sept 14 [cited 2025 Sept 1];294(10):[1215 p.]. Available from: http:\/\/jama.jamanetwork.com\/article.aspx?doi=https:\/\/doi.org\/10.1001\/jama.294.10.1215","DOI":"10.1001\/jama.294.10.1215"},{"key":"1248_CR19","doi-asserted-by":"crossref","unstructured":"R\u00e4ber L, Yamaji K, Kelb\u00e6k H, Engstr\u00f8m T, Baumbach A, Roffi M, et al. Five-year clinical outcomes and intracoronary imaging findings of the COMFORTABLE AMI trial: randomized comparison of biodegradable polymer-based biolimus-eluting stents with bare-metal stents in patients with acute ST-segment elevation myocardial infarction. Eur Heart J. 2019 June 21 [cited 2025 Sept 1];40(24):[1909\u201319 p.]. Available from: https:\/\/academic.oup.com\/eurheartj\/article\/40\/24\/1909\/5372331","DOI":"10.1093\/eurheartj\/ehz074"},{"key":"1248_CR20","unstructured":"Tamez H, Secemsky E, Valsdottir L, Moussa I, Song Y, Simonton C, et al. Long-term outcomes of percutaneous coronary intervention for in-stent restenosis among Medicare beneficiaries. [cited 2025 Sept 1]. Available from: https:\/\/eurointervention.pcronline.com\/article\/long-term-outcomes-of-in-stent-restenosis-percutaneous-coronary-intervention-among-medicare-beneficiaries"},{"key":"1248_CR21","doi-asserted-by":"crossref","unstructured":"Rohman MS, Waranugraha Y, Masbuchin AN, Baskoro SS, Sishartami LW, Pratiwi BB. Coronary In-Stent Restenosis Predictors following Drug-Eluting Stent Implantation: A Meta-Analysis Study. J Vasc Dis. 2023 Sept [cited 2025 Sept 1];2(3):[266\u201381 p.]. Available from: https:\/\/www.mdpi.com\/2813-2475\/2\/3\/20","DOI":"10.3390\/jvd2030020"},{"key":"1248_CR22","doi-asserted-by":"crossref","unstructured":"Liu B, Li M, Liu J, Xie L, Li J, Liu Y, et al. Risk Factors and Incidence for In-Stent Restenosis with Drug-Eluting Stent: A Systematic Review and Meta-Analysis. Rev Cardiovasc Med. 2024 Dec 24 [cited 2025 Sept 1];25(12):[458 p.]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC11683691\/","DOI":"10.31083\/j.rcm2512458"},{"key":"1248_CR23","doi-asserted-by":"publisher","unstructured":"Giustino G, Colombo A, Camaj A, Yasumura K, Mehran R, Stone GW, et al. Coronary In-Stent Restenosis. JACC. 2022 July 26 [cited 2025 Sept 1];80(4):[348\u201372 p.]. Available from: https:\/\/www.jacc.org\/doi\/https:\/\/doi.org\/10.1016\/j.jacc.2022.05.017","DOI":"10.1016\/j.jacc.2022.05.017"},{"key":"1248_CR24","doi-asserted-by":"publisher","unstructured":"Kim YH, Park DW, Lee SW, Yun SC, Lee CW, Hong MK, et al. Long-Term Safety and Effectiveness of Unprotected Left Main Coronary Stenting With Drug-Eluting Stents Compared With Bare-Metal Stents. Circulation. 2009 Aug 4 [cited 2025 Sept 1];120(5):[400\u20137 p.]. Available from: https:\/\/www.ahajournals.org\/doi\/https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.108.800805","DOI":"10.1161\/CIRCULATIONAHA.108.800805"},{"key":"1248_CR25","doi-asserted-by":"publisher","unstructured":"Moussa ID, Mohananey D, Saucedo J, Stone GW, Yeh RW, Kennedy KF, et al. Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States. JACC. 2020 Sept 29 [cited 2025 Sept 1];76(13):[1521\u201331 p.]. Available from: https:\/\/www.jacc.org\/doi\/https:\/\/doi.org\/10.1016\/j.jacc.2020.08.002","DOI":"10.1016\/j.jacc.2020.08.002"},{"key":"1248_CR26","doi-asserted-by":"crossref","unstructured":"Byrne RA, Neumann FJ, Mehilli J, Pinieck S, Wolff B, Tiroch K, et al. Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. The Lancet. 2013 Feb [cited 2025 Sept 1];381(9865):[461\u20137 p.]. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673612619643","DOI":"10.1016\/S0140-6736(12)61964-3"},{"key":"1248_CR27","doi-asserted-by":"publisher","unstructured":"Xu B, Gao R, Wang J, Yang Y, Chen S, Liu B, et al. A Prospective, Multicenter, Randomized Trial of Paclitaxel-Coated Balloon Versus Paclitaxel-Eluting Stent for the Treatment of Drug-Eluting Stent In-Stent Restenosis. JACC: CardiovasInterv. 2014 Feb [cited 2025 Sept 1];7(2):[204\u201311 p.]. Available from: https:\/\/www.jacc.org\/doi\/https:\/\/doi.org\/10.1016\/j.jcin.2013.08.011","DOI":"10.1016\/j.jcin.2013.08.011"},{"issue":"1","key":"1248_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.jacc.2015.04.063","volume":"66","author":"F Alfonso","year":"2015","unstructured":"Alfonso F, P\u00e9rez-Vizcayno MJ, C\u00e1rdenas A, Garc\u00eda del Blanco B, Garc\u00eda-Touchard A, L\u00f3pez-Mingu\u00e9z JR, et al. A Prospective Randomized Trial of Drug-Eluting Balloons Versus Everolimus-Eluting Stents in Patients With In-Stent Restenosis of Drug-Eluting Stents: The RIBS IV Randomized Clinical Trial. J Am Coll Cardiol. 2015;66(1):23\u201333.","journal-title":"J Am Coll Cardiol"},{"key":"1248_CR29","doi-asserted-by":"crossref","unstructured":"Alfonso F, P\u00e9rez-Vizcayno MJ, Cuesta J, Garc\u00eda Del Blanco B, Garc\u00eda-Touchard A, L\u00f3pez-M\u00ednguez JR, et al. 3-Year Clinical Follow-Up of the RIBS IV Clinical Trial. JACC: CardiovasInterv. 2018 May [cited 2025 Sept 1];11(10):[981\u201391 p.]. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879818306563","DOI":"10.1016\/j.jcin.2018.02.037"},{"key":"1248_CR30","doi-asserted-by":"publisher","unstructured":"Kleber FX, Rittger H, Bonaventura K, Zeymer U, W\u00f6hrle J, Jeger R, et al. Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol. 2013 Nov [cited 2025 Sept 1];102(11):[785\u201397 p.]. Available from: http:\/\/link.springer.com\/https:\/\/doi.org\/10.1007\/s00392-013-0609-7","DOI":"10.1007\/s00392-013-0609-7"},{"issue":"16","key":"1248_CR31","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1136\/hrt.2010.195057","volume":"96","author":"B Cortese","year":"2010","unstructured":"Cortese B, Micheli A, Picchi A, Coppolaro A, Bandinelli L, Severi S, et al. Paclitaxel-coated balloon versus drug-eluting stent during PCI of small coronary vessels, a prospective randomised clinical trial. The PICCOLETO study. Heart. 2010;96(16):1291\u20136.","journal-title":"Heart"},{"key":"1248_CR32","doi-asserted-by":"crossref","unstructured":"Leone PP, Heang TM, Yan LC, Perez IS, Caiazzo G, Geraci S, et al. Two-year outcomes of sirolimus-coated balloon angioplasty for coronary artery disease: the EASTBOURNE Registry 2025. https:\/\/eurointervention.pcronline.com\/article\/two-year-outcomes-of-sirolimus-coated-balloon-angioplasty-for-coronary-artery-disease-the-eastbourne-registry","DOI":"10.4244\/EIJ-D-23-00966"},{"issue":"3","key":"1248_CR33","first-page":"425","volume":"104","author":"D Shin","year":"2024","unstructured":"Shin D, Singh M, Shlofmitz E, Scheller B, Latib A, Kandzari DE, et al. Paclitaxel-coated versus sirolimus-coated balloon angioplasty for coronary artery disease: a systematic review and meta-analysis. Catheter Cardiovasc Interv. 2024;104(3):425\u201336.","journal-title":"Catheter Cardiovasc Interv"},{"key":"1248_CR34","doi-asserted-by":"crossref","unstructured":"Bhogal S, Hill AP, Merdler I, Wermers JP, Ben-Dor I, Waksman R. Drug-coated balloons for coronary artery disease: An updated review with future perspectives. Cardiovas Revas Med. 2024 Dec [cited 2025 Sept 1];69:[79\u201389 p.]. Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838924004962","DOI":"10.1016\/j.carrev.2024.05.027"},{"key":"1248_CR35","doi-asserted-by":"crossref","unstructured":"Sedhom R, Hamed M, Elbadawi A, Mohsen A, Swamy P, Athar A, et al. Outcomes With Limus- vs Paclitaxel-Coated Balloons for Percutaneous Coronary Intervention: Meta-Analysis of Randomized Controlled Trials. JACC: Cardiovas Interv. 2024 July 8 [cited 2025 Sept 1];17(13):[1533\u201343 p.]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S193687982400712X3","DOI":"10.1016\/j.jcin.2024.04.042"},{"key":"1248_CR36","doi-asserted-by":"crossref","unstructured":"Erdogan E, Bajaj R, Lansky A, Mathur A, Baumbach A, Bourantas CV. Intravascular Imaging for Guiding In\u2010Stent Restenosis and Stent Thrombosis Therapy. J Am Heart Assoc. 2022 Nov 3 [cited 2025 Dec 28];11(22):[e026492 p.]. Available from: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC9750080\/","DOI":"10.1161\/JAHA.122.026492"},{"issue":"16","key":"1248_CR37","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1136\/heartjnl-2012-302183","volume":"98","author":"F Alfonso","year":"2012","unstructured":"Alfonso F, Dutary J, Paulo M, Gonzalo N, P\u00e9rez-Vizcayno MJ, Jim\u00e9nez-Quevedo P, et al. Combined use of optical coherence tomography and intravascular ultrasound imaging in patients undergoing coronary interventions for stent thrombosis. Heart. 2012;98(16):1213\u201320.","journal-title":"Heart"},{"key":"1248_CR38","doi-asserted-by":"publisher","unstructured":"Simonetti F, Cassese S, Carassia C, Lenz T, Blum E, Alvarez Covarrubias HA, et al. Intravascular Imaging for Stent Failure - Current Status and Future Perspectives. Curr Cardiovasc Imaging Rep. 2025 July 30 [cited 2025 Dec 28];18(1):[9 p.]. Available from: https:\/\/doi.org\/10.1007\/s12410-025-09606-1","DOI":"10.1007\/s12410-025-09606-1"}],"container-title":["Cardiovascular Intervention and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01248-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12928-026-01248-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12928-026-01248-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T19:04:59Z","timestamp":1781809499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12928-026-01248-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,3]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1248"],"URL":"https:\/\/doi.org\/10.1007\/s12928-026-01248-4","relation":{},"ISSN":["1868-4300","1868-4297"],"issn-type":[{"value":"1868-4300","type":"print"},{"value":"1868-4297","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,3]]},"assertion":[{"value":"1 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors certify that they have no affiliations with or involvement in any organization or entity with any financial or non-financial interest in the subject matter or materials discussed in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable. This is a meta-analysis. The Sirio Libanes Research Ethics Committee has confirmed that no ethical approval is required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}]}}